Picture of BioNeutra Global logo

BGA BioNeutra Global Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapContrarian

Annual cashflow statement for BioNeutra Global, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.163.1-12.4-3.71-2.83
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items3.161.020.5270.461
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.964-2.7410.72.840.777
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities2.252.910.7081.430.271
Capital Expenditures-2.01-0.823-0.237-0.076-0.277
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items00.5160.050
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-2.01-0.8230.278-0.026-0.277
Financing Cash Flow Items-0.478-0.527-0.534-0.387-0.35
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.086-1.65-1.66-0.9-0.298
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.7940.112-0.9740.411-0.095

Or unlock with your email

Or unlock with your email